Completed
Crizanlizumab for Treatment of Retinal Vasculopathy With Cerebral Leukoencephalopathy (RVCL)
NCT04611880
- Conditions
- RVCL - Retinal Vasculopathy Cerebral Leukoencephalopathy, Vasculopathy, Retinal, With Cerebral Leukodystrophy
- Locations
-
- Andria Ford St Louis, Missouri, United States
- Perelman School of Medicine; University of Pennsylvania Philadelphia, Pennsylvania, United States